BSE: 544106
Mayank Cattle Food Limited
Manufactures maize oil and maize cake (cattle feed) as a single operating segment, reporting Rs. 40,316.70 lakhs in revenue from operations for FY26, up 3.15% from Rs. 39,085.79 lakhs in FY25. Profit after tax rose to Rs. 601.81 lakhs from Rs. 497.25 lakhs, with basic EPS of Rs. 11.14 against Rs. 9.21. The product range is being extended: groundnut oil production commenced on April 28, 2026 in both household and HoReCa (hotel, restaurant, catering) packs, and three new cattle nutritional supplements — MAYANK VITA H LIQUID, MAYANK FAT and MAYANK CAL GOLD — were launched in May 2026 to support milk fat, calcium balance and overall livestock health. All output is targeted at the domestic market, with no exports planned initially. Cost structure is heavily raw-material driven, with materials accounting for 92.1% of revenue, employee costs at 1.2% and other operating expenses at 2.8%, while capex ran at 0.4% of revenue at Rs. 1.795 crore. The board remains controlled by the Vachhani family, with four of five directors (Managing Director and three Whole-time Directors) drawn from it. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Manufacturing of Maize Oil & Maize Cake (100%). Single-segment, family-controlled FMCG and animal-feed manufacturer; raw-material-heavy, low-capex
Exhibit 1: Financial summary, FY25–FY25 (all audited; no estimate years)
| ₹ crore · consolidated | FY25 |
|---|---|
| Revenue | 392 |
| EBITDA (ex other income) | — |
| margin % | — |
| Owners' profit | — |
| EPS, as reported (₹) | 9.33 |
| ROE % · ROCE % | — · 28.9 |
| Debt / equity (x) | — |
| Cash from operations | 12 |
| Capex | (8) |
Exhibit 2: Quarterly performance, last 3 quarters
| ₹ crore | Q2 FY25 | Q4 FY25 | Q2 FY26 |
|---|---|---|---|
| Revenue | 179 | 213 | 187 |
| Profit before tax | 3 | 4 | 3 |
| Net profit | — | — | — |
| EPS (₹) | 3.79 | 5.54 | 4.66 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| GODREJ AGROVET LIMITED | 11,224 | 25.1 | 5.19 | 13.2 | 20.6 | 17.6 | 10.3 | 8.9 |
| AVANTI FEEDS LIMITED | 9,169 | 17.3 | 2.47 | 9.7 | 17.7 | 23.5 | 8.1 | 9.0 |
| MUKKA PROTEINS LIMITED | 747 | 10.8 | 1.41 | 10.5 | 10.8 | 12.8 | — | 10.1 |
| KSE LTD. | 563 | 0.8 | 1.61 | — | 24.0 | 30.5 | — | (0.5) |
| SHIVAM CHEMICALS LIMITED | 247 | 29.6 | — | — | — | 17.8 | — | — |
| Mayank Cattle Food Limited ◆ | 63 | 8.3 | — | — | — | — | — | — |
| AJOONI BIOTECH LIMITED | 50 | 12.1 | 0.55 | — | 4.7 | 6.2 | — | 3.1 |
| NARMADA AGROBASE LIMITED | 44 | 57.5 | — | — | — | — | — | 5.5 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 8.3 | 14.7 | 2 of 8 | 86% |
| Market cap | 63 | 405 | 6 of 8 | 29% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 27 Oct 2026 · H1 FY2026-27 revenue up 12.56%, profit after tax up 119.73% | results | high | — | — |
| 27 Oct 2026 · Profit nearly doubles as revenue rises 12.6% in H1 ended September 2026 | results | high | — | — |
| 27 Oct 2026 · Revenue rises 13%, half-year profit more than doubles | results | medium | — | — |
| 22 Oct 2026 · Board meeting on Oct 27 to approve H1 FY27 unaudited results | results | low | — | — |
| 13 Oct 2026 · Routine compliance certificate for share dematerialisation, Q2 FY27 | compliance | minimal | — | — |
| 23 Sept 2026 · Trading window closed from Oct 1 ahead of H1 FY26 results | compliance | minimal | — | — |
| 25 Aug 2026 · Bonus Shares Allotted in 1:1 Ratio | corporate actions | high | — | — |
| 24 Aug 2026 · Mayank Cattle Food launches new udder health product MAYANK UDDERSAFE | business updates | low | — | — |
| 8 Aug 2026 · Mayank Cattle Food fixes record date for 1:1 bonus shares | corporate actions | high | — | — |
| 8 Aug 2026 · AGM voting results: All 15 resolutions passed, bonus issue approved | board shareholder meetings | low | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.